Sudo Biosciences

Advancing precision therapeutics for challenging conditions

Employees
11–50
Business Model
B2B
Total Funding
$183.0M
Last Round
$30.0M Extension RoundDec 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sudo Biosciences is focused on first- and best-in-class neurological and immune-mediated medicine. Sudo Biosciences lead programs target TYK2, which is believed to be linked to serious immunological and neurological conditions. The company’s research focuses on serious conditions with medical need, with the goal of delivering transformative therapeutics for patients. Company management includes experienced scientists and leaders in small molecule drug discovery and development.

Summary

Sudo Biosciences is a Biotech company. It has raised $183.0M in total across 3 rounds, most recently a $30.0M Extension Round in Dec 2023. Investors include Frazier Life Sciences, Velosity Capital and Enavate Sciences.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2023
$116.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sudo Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/sudo-biosciences"><img src="https://indexed.vc/api/badge/company/sudo-biosciences" alt="Sudo Biosciences on Indexed.vc" width="260" height="76" /></a>